Search
Search Results
##search.searchResults.foundPlural##
-
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1120PDF: 882HTML: 267 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1812PDF: 1010HTML: 1805Tables: 187 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13308PDF: 994HTML: 7300 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1381PDF: 1269HTML: 484 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2814PDF: 920HTML: 258 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3095PDF: 1035HTML: 3140 -
Pseudo-differentiation syndrome
1406PDF: 681HTML: 10855Figure 1: peripheral blood showing myeloblasts with auer rods: 128Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 112Figure 3: CXR showing pulmonary infiltartes with consolidation: 140Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 123Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 122 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
979PDF: 578HTML: 2211Cover Letter: 202 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1250PDF: 941HTML: 314 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3115PDF: 890HTML: 7219Kost Fig1: 202Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 205Kost Fig5: 203Kost fig 6: 189 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2021PDF: 1024HTML: 736 -
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2919PDF: 1460HTML: 3067Cover Letter: 220 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1152PDF: 554HTML: 1702Figures: 181Fifures Sanz: 187tables Sanz: 189Untitled: 185 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3765PDF: 1323HTML: 786Figure 2: 466Figure 1: 3146 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7163PDF: 4030HTML: 24919 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3328PDF: 1567HTML: 458 -
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
1617PDF: 807HTML: 830tile page: 171Table 1: 178 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1665PDF: 811HTML: 871jdoe, table 2 infections CML .doc: 205jdoe, table 1 infections CML .doc: 195 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
907PDF: 515HTML: 215Suppl. Files: 335 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4067PDF: 1564HTML: 9214Untitled: 287Untitled: 195Untitled: 180Untitled: 173Untitled: 196Untitled: 352







